Despite the indolent nature of LPL and a median survival exceeding 10 years from diagnosis, 2–10% of patients eventually develop DLBCL, typically exhibiting the non-GCB phenotype, associated with a poor prognosis [4,21,41]. Here, LPL is linked to diffuse large B-cell lymphoma.